跳至主要内容
临床试验/JPRN-UMIN000041042
JPRN-UMIN000041042已完成2 期

Double-blind randomized controlled trial to examine the effects of a highly absorbable curcumin oral agent on lymphocyte type and count in the elderly - Highly absorbable curcumin and lymphocyte types in the elderly

ational Hospital Organization Kyoto Medical Center0 个研究点目标入组 40 人开始时间: 2020年7月9日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Persons who fall under any of the following criteria will be excluded from the study. 1)Persons who regularly consume health foods containing curcumin 2)Persons who have a history of allergy to curcumin 3)Persons who are pregnant or breastfeeding 4)Persons who undergoing treatment for malignant tumor 5)Persons who regularly take an antibiotic or steroid 6)Persons who are taking two or more antiplatelet agents or a single antiplatelet agent with another antithrombotic agent (e.g., anticoagulant, EPA agent, prostacyclin agent) 7)Persons who have a history of cerebral hemorrhage and are taking a single antiplatelet agent 8)Persons undergoing home oxygen therapy 9)Persons undergoing dialysis due to renal failure 10)Persons with severe liver dysfunction/cirrhosis 11)Persons with severe cardiac dysfunction (left ventricular ejection fraction less than 20%) 12)In addition, persons for whom the research director or co-researcherinvestigators determine to be inappropriate for participation in this research

研究者

发起方
ational Hospital Organization Kyoto Medical Center

相似试验